Name of applicant:
|
GSK plc
| |||
Name of scheme:
|
GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
| |||
Period of return:
|
From:
|
1 November 2023
|
To:
|
30 April 2024
|
Balance of unallotted securities under scheme(s) from previous return:
|
271,307
| |||
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
| |||
Less:Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
155,789
| |||
Equals:Balance under scheme(s) not yet issued/allotted at end of period:
|
115,518
|
Name of applicant:
|
GSK plc
| |||
Name of scheme:
|
GlaxoSmithKline plc Share Save Plan 2012
| |||
Period of return:
|
From:
|
1 November 2023
|
To:
|
30 April 2024
|
Balance of unallotted securities under scheme(s) from previous return:
|
506,598
| |||
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
2,000,000
| |||
Less:Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
1,833,574
| |||
Equals:Balance under scheme(s) not yet issued/allotted at end of period:
|
673,024
|
Name of applicant:
|
GSK plc
| |||
Name of scheme:
|
GlaxoSmithKline plc Share Save Plan 2022
| |||
Period of return:
|
From:
|
1 November 2023
|
To:
|
30 April 2024
|
Balance of unallotted securities under scheme(s) from previous return:
|
999,109
| |||
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
| |||
Less:Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
3,852
| |||
Equals:Balance under scheme(s) not yet issued/allotted at end of period:
|
995,257
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
GSK plc
| |
(Registrant)
| |
Date: May 13, 2024
| |
By:/s/ VICTORIA WHYTE
--------------------------
| |
Victoria Whyte
| |
Authorised Signatory for and on
| |
behalf of GSK plc
|
Attachments
- Original Link
- Permalink
Disclaimer
GSK plc published this content on 13 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 May 2024 14:52:06 UTC.